Imaging Diagnostics Systems' CT laser mammo gets closer to US
This article was originally published in Clinica
Executive Summary
Imaging Diagnostics Systems' (IDS) CT laser mammography (CTLM) system is edging closer to the US market, the company told Clinica, after enrolling a tenth site in clinical trials of the technology. Results of the study will be used in its premarket approval (PMA) application to the US FDA. The Fort Lauderdale, Florida company may add two further sites to the trial to "further shorten the time" needed to collect enough patient data to submit for approval.